• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用聚(赖氨酸-g-(丙交酯-b-乙二醇))三元共聚物进行纳米颗粒DNA包装

Nanoparticulate DNA packaging using terpolymers of poly(lysine-g-(lactide-b-ethylene glycol)).

作者信息

Park Susan, Healy Kevin E

机构信息

University of California at Berkeley, Department of Bioengineering, 459 Evans Hall, 94270-1762, USA.

出版信息

Bioconjug Chem. 2003 Mar-Apr;14(2):311-9. doi: 10.1021/bc025623b.

DOI:10.1021/bc025623b
PMID:12643741
Abstract

Terpolymers of poly(lysine-g-(lactide-b-ethylene glycol)) (pK-pLL-pEG) were synthesized by using ring-opening polymerization and functional end-group grafting. Synthesis was characterized with gel permeation chromatography, proton nuclear magnetic resonance spectroscopy, and a trinitrobenzene sulfonic acid binding assay. Polymer association behavior with DNA was investigated using an ethidium bromide exclusion assay, static light scattering, and scanning electron microscopy. Polylactide molecular weight was varied to investigate its impact on DNA association and resulting complex characteristics. Polylysine ( = 8800, DP = 42) modified with either 7400 or 10 870 pLL-pEG reduced the minimum amount of primary amines necessary for complete condensation by 23% and 48%, respectively, compared to unmodified polylysine (pK42). Complexes formed with the highest molecular weight terpolymer demonstrated significantly (p < 0.1) greater resistance to DNase I than lyophilized pK42-DNA particles. This study suggests that modification of pK42 with pLL-pEG diblock copolymers impacts polylysine's associative and binding behavior to DNA and resulting particle characteristics. Modulation of terpolymer composition in complexes can enable control over intracellular plasmid dissociation rates to improve transfection efficiency.

摘要

通过开环聚合和官能端基接枝合成了聚(赖氨酸 - g -(丙交酯 - b - 乙二醇))(pK - pLL - pEG)三元共聚物。通过凝胶渗透色谱、质子核磁共振光谱和三硝基苯磺酸结合测定对合成进行了表征。使用溴化乙锭排除测定、静态光散射和扫描电子显微镜研究了聚合物与DNA的缔合行为。改变聚丙交酯的分子量以研究其对DNA缔合和所得复合物特性的影响。与未修饰的聚赖氨酸(pK42)相比,用7400或10870 pLL - pEG修饰的聚赖氨酸( = 8800,DP = 42)分别将完全缩合所需的伯胺的最小量降低了23%和48%。与冻干的pK42 - DNA颗粒相比,由最高分子量三元共聚物形成的复合物对DNase I表现出显著(p < 0.1)更高的抗性。这项研究表明,用pLL - pEG二嵌段共聚物修饰pK42会影响聚赖氨酸与DNA的缔合和结合行为以及所得颗粒的特性。调节复合物中三元共聚物的组成可以控制细胞内质粒的解离速率,以提高转染效率。

相似文献

1
Nanoparticulate DNA packaging using terpolymers of poly(lysine-g-(lactide-b-ethylene glycol)).使用聚(赖氨酸-g-(丙交酯-b-乙二醇))三元共聚物进行纳米颗粒DNA包装
Bioconjug Chem. 2003 Mar-Apr;14(2):311-9. doi: 10.1021/bc025623b.
2
Compositional regulation of poly(lysine-g-(lactide-b-ethylene glycol))-DNA complexation and stability.
J Control Release. 2004 Mar 24;95(3):639-51. doi: 10.1016/j.jconrel.2003.12.002.
3
Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-tapgeted gene carrier.乳糖-聚乙二醇接枝的聚-L-赖氨酸作为肝癌细胞靶向基因载体
Bioconjug Chem. 1998 Nov-Dec;9(6):708-18. doi: 10.1021/bc980017v.
4
Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers.可降解的聚乙烯亚胺-alt-聚(乙二醇)共聚物作为新型基因载体。
J Control Release. 2005 Jul 20;105(3):367-80. doi: 10.1016/j.jconrel.2005.04.008.
5
Study on galactose-poly(ethylene glycol)-poly(L-lysine) as novel gene vector for targeting hepatocytes in vitro.体外靶向肝细胞的新型基因载体半乳糖-聚乙二醇-聚(L-赖氨酸)的研究。
J Biomater Sci Polym Ed. 2012;23(5):677-95. doi: 10.1163/092050611X558297. Epub 2011 Mar 4.
6
Novel symmetric amphiphilic dendritic poly(L-lysine)-b-poly(L-lactide)-b-dendritic poly(L-lysine) with high plasmid DNA binding affinity as a biodegradable gene carrier.具有高质粒DNA结合亲和力的新型对称两亲性树枝状聚(L-赖氨酸)-b-聚(L-丙交酯)-b-树枝状聚(L-赖氨酸)作为可生物降解的基因载体。
Biomacromolecules. 2007 May;8(5):1409-16. doi: 10.1021/bm0701806. Epub 2007 Apr 26.
7
Low molecular weight linear polyethylenimine-b-poly(ethylene glycol)-b-polyethylenimine triblock copolymers: synthesis, characterization, and in vitro gene transfer properties.低分子量线性聚乙烯亚胺-b-聚(乙二醇)-b-聚乙烯亚胺三嵌段共聚物:合成、表征及体外基因转移特性
Biomacromolecules. 2005 Nov-Dec;6(6):3440-8. doi: 10.1021/bm050505n.
8
Sustained delivery and expression of plasmid DNA based on biodegradable polyester, poly(D,L-lactide-co-4-hydroxy-L-proline).基于可生物降解聚酯聚(D,L-丙交酯-co-4-羟基-L-脯氨酸)的质粒DNA的持续递送与表达。
J Control Release. 2004 Aug 27;98(3):437-46. doi: 10.1016/j.jconrel.2004.05.013.
9
In-situ formation of biodegradable hydrogels by stereocomplexation of PEG-(PLLA)8 and PEG-(PDLA)8 star block copolymers.通过聚乙二醇-(聚左旋乳酸)8和聚乙二醇-(聚右旋乳酸)8星型嵌段共聚物的立体复合作用原位形成可生物降解水凝胶。
Biomacromolecules. 2006 Oct;7(10):2790-5. doi: 10.1021/bm060630e.
10
Characterization of PLL-g-PEG-DNA nanoparticles for the delivery of therapeutic DNA.用于治疗性DNA递送的聚赖氨酸-聚乙二醇-脱氧核糖核酸纳米颗粒的表征
Bioconjug Chem. 2008 Feb;19(2):548-57. doi: 10.1021/bc7003439. Epub 2008 Jan 4.

引用本文的文献

1
Heterometallic Li/Zn, Li/Al and Li/In catalysts for -lactide ring-opening polymerisation: "ate" or "non-ate" pathways?用于丙交酯开环聚合的异金属锂/锌、锂/铝和锂/铟催化剂:“ate”途径还是“非ate”途径?
Catal Sci Technol. 2025 Sep 3. doi: 10.1039/d5cy00872g.
2
Cationic Materials for Gene Therapy: A Look Back to the Birth and Development of 2,2-Bis-(hydroxymethyl)Propanoic Acid-Based Dendrimer Scaffolds.阳离子材料在基因治疗中的应用:回溯基于 2,2-双羟甲基丙酸的树枝状大分子支架的诞生和发展。
Int J Mol Sci. 2023 Nov 6;24(21):16006. doi: 10.3390/ijms242116006.
3
Cancer drug delivery in the nano era: An overview and perspectives (Review).
纳米时代的癌症药物递送:综述与展望(综述)
Oncol Rep. 2017 Aug;38(2):611-624. doi: 10.3892/or.2017.5718. Epub 2017 Jun 14.
4
Biomaterials and bioengineering tomorrow's healthcare.生物材料与生物工程塑造明日医疗保健。
Biomatter. 2013 Jul-Sep;3(3). doi: 10.4161/biom.24717. Epub 2013 Apr 1.
5
Drug releasing systems in cardiovascular tissue engineering.心血管组织工程中的药物释放系统。
J Cell Mol Med. 2009 Mar;13(3):422-39. doi: 10.1111/j.1582-4934.2008.00532.x.
6
Suppression of the progress of disseminated pancreatic cancer cells by NK4 plasmid DNA released from cationized gelatin microspheres.阳离子化明胶微球释放的NK4质粒DNA对播散性胰腺癌细胞进展的抑制作用
Pharm Res. 2004 Jul;21(7):1109-18. doi: 10.1023/b:pham.0000032996.95518.dc.